Skip to Content
Genenta Science Investors
Upcoming Events
Past Events
Investing in the best Italian tech entrepreneurs: from seed to unicorn
Jun 15, 2022 from 5:30 PM to 7:30 PM BST
One Great George Street, Westminster, London SW1P 3AA

Speakers:
MC Carolina Neri, Director at Finsbury Glover Hering
Massimo Carnelos, Head of the Economic Office of the Embassy of Italy in London
Giancarlo Rocchietti, Founder and President at Club degli Investitori
Andrea Rota, Managing Director at Club degli Investitori
Gioia Manetti, Member at Club degli Investitori

 

Keynote speakers:
Luca Rossettini, founder and CEO at D-Orbit
Pierluigi Paracchi, founder and CEO at Genenta
Stefano Buono, founder and CEO at Newcleo

European Hematology Association (EHA) 2022 Virtual Congress
Jun 10, 2022 at 4:30 PM CEST to May 10, 2022 at 10:45 PM CEST
Vienna and virtual

Title: Using Gene-Modified Autologous Stem Cells Progeny to Reeducate the Tumor Immune Microenvironment of Solid Tumors (TEM-GBM Study)

Type: Poster presentation

Brain Tumor Meeting (BTM) 2022
Jun 5, 2022 from 8:00 AM to 11:00 AM EDT
Berlin

Title: Harnessing genetically engineered hematopoietic progenitor cells to redirect the tumor immune microenvironment against glioblastoma (TEM-GBM Study)

Type: Poster presentation

EuropaBio - SME BioForum
May 31, 2022 at 11:00 AM CEST

EuropaBio - the European Association for Bioindustries, round table discussion within SME Bioforum about the business environment for Advanced Therapy Medicinal Products (ATMPs) in Europe

 

The Meeting is online and invitation only.

 

Speaker:
Pierluigi Paracchi, CEO and Co-Founder -  Genenta Science

2022 RBCCM Global Healthcare Conference Website
May 18, 2022 at 11:00 AM EDT
In person event at the InterContinental Barclay NY

Webcasting information: Fireside chats will be webcasted via Open Exchange. Additional details will be provided closer to the conference.

 

Speaker:
Pierluigi Paracchi, CEO and Co-founder
Carlo Russo, Chief Medical Officer & Head of Development

BIOequity Europe 2022
May 17, 2022 at 2:30 PM CEST

Tuesday May 17, 2:30-3:30 p.m. CET
West-East Roundtable: The Clinical Pathway to Europe-China Collaborations

 

Session Chair & Panelists:

  • Joshua Berlin, Head of Business Development, BioCentury Inc. (Session Chair)
  • Georg Büchner, Ph.D., Group Chief Business Officer, Helsinn Group
  • James Huang, Founding Managing Partner, Panacea Healthcare Venture; Managing Partner, KPCB China 
  • Stefania Mazzoleni Ph.D., Scientific Project Manager & Communication Officer, Genenta Science S.p.A
  • Steven Powell, Ph.D., CEO, eTheRNA immunotherapies N.V.
  • Debra Yu, M.D., President & Chief Strategy Officer, LianBio
  • Guo-Liang Yu, Ph.D., Chairman, BayHelix; Co-Founder, Chairman & CEO, Apollomics Inc.
Investor Contact
RSS Feeds
Print